UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics

European journal of nuclear medicine and molecular imaging, 2021-12, Vol.49 (1), p.385-389

2021

Volltextzugriff (PDF)

Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor

Frontiers in oncology, 2022-05, Vol.12, p.864708-864708

2022

Volltextzugriff (PDF)

Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor: A hospital‐based cancer registry data in Japan

International journal of urology, 2020-02, Vol.27 (2), p.163-164

2020

Volltextzugriff (PDF)

The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer

Current molecular medicine, 2022-12, Vol.22 (10), p.941-949

2022

Volltextzugriff (PDF)

Editorial Comment from Dr Szarvas to Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: A mini-review

International journal of urology, 2014-08, Vol.21 (8), p.753-753

Szarvas, Tibor

2014

Volltextzugriff (PDF)

A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer

Laboratory investigation, 2021-09, Vol.101 (9), p.1281-1288

2021

Volltextzugriff (PDF)

Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation: a systematic review and meta-analysis

Reproductive biology and endocrinology, 2023-01, Vol.21 (1), p.5-5, Article 5

2023

Volltextzugriff (PDF)

Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases

Urologic oncology, 2016-09, Vol.34 (9), p.388-398

2016

Volltextzugriff (PDF)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7431

2021

Volltextzugriff (PDF)

Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma

PloS one, 2017-04, Vol.12 (4), p.e0176287-e0176287

2017

Volltextzugriff (PDF)

Editorial Comment to Identification of tumor immunophenotypes associated with immunotherapy response in bladder cancer

International journal of urology, 2023-12, Vol.30 (12), p.1132-1133

Szarvas, Tibor

2023

Volltextzugriff (PDF)

Editorial Comment to Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy

International journal of urology, 2013-09, Vol.20 (9), p.872-872

Szarvas, Tibor

2013

Volltextzugriff (PDF)

Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer

Laboratory investigation, 2021-10, Vol.101 (10), p.1414-1414

2021

Volltextzugriff (PDF)

Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study

Scientific reports, 2023-10, Vol.13 (1), p.17378-17378, Article 17378

2023

Volltextzugriff (PDF)

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens

BMC cancer, 2023-06, Vol.23 (1), p.504-504, Article 504

2023

Volltextzugriff (PDF)

The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells

Molecular cancer, 2015-05, Vol.14 (1), p.108-108, Article 108

2015

Volltextzugriff (PDF)

Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma: A Combined Cohort Analysis, Systematic Review, and Meta-Analysis

International journal of molecular sciences, 2023-04, Vol.24 (9), p.7859

2023

Volltextzugriff (PDF)

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis

Molecular cancer, 2023-03, Vol.22 (1), p.52-52, Article 52

2023

Volltextzugriff (PDF)

Correction to: COVID-19 research: promising tracks leading to uro-oncology

International urology and nephrology, 2021, Vol.53 (1), p.95-95

2021

Volltextzugriff (PDF)

Matrix metalloproteinase‐7 as a marker of metastasis and predictor of poor survival in bladder cancer

Cancer science, 2010-05, Vol.101 (5), p.1300-1308

2010

Volltextzugriff (PDF)

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder

The Journal of pathology, 2024-08, Vol.263 (4-5), p.400-402

2024

Volltextzugriff (PDF)

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy

Cancers, 2021-05, Vol.13 (11), p.2548

2021

Volltextzugriff (PDF)

Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness

Urologic oncology, 2014-11, Vol.32 (8), p.1166-1171

2014

Volltextzugriff (PDF)

Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer

The Prostate, 2016-08, Vol.76 (11), p.977-985

2016

Volltextzugriff (PDF)

Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer

Pathology international, 2017-12, Vol.67 (12), p.597-601

2017

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(145)

Publikationsform

Artikel
(182)
Dissertationen
(2)

Sprache

Englisch
(172)
Ungarisch
(13)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(117)
Humans
(93)
Male
(69)
Oncology
(54)
Middle Aged
(50)
Female
(48)
Prognosis
(48)
Aged
(47)
Urology & Nephrology
(45)
Bladder Cancer
(44)
Urinary Bladder Neoplasms - Pathology
(31)
Urology
(27)
Cancer
(26)
Adult
(23)
Metastasis
(22)
Tumors
(22)
Aged, 80 And Over
(21)
Patients
(21)
Prostate Cancer
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics

Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor

Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor: A hospital‐based cancer registry data in Japan

The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer

Editorial Comment from Dr Szarvas to Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: A mini-review

A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer

Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation: a systematic review and meta-analysis

Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer

Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma

Editorial Comment to Identification of tumor immunophenotypes associated with immunotherapy response in bladder cancer

Editorial Comment to Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy

Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer

Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens

The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells

Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma: A Combined Cohort Analysis, Systematic Review, and Meta-Analysis

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis

Correction to: COVID-19 research: promising tracks leading to uro-oncology

Matrix metalloproteinase‐7 as a marker of metastasis and predictor of poor survival in bladder cancer

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy

Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness

Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer

Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer

Suchergebnisse filtern